Skip to main content
Premium Trial:

Request an Annual Quote

PierianDx Closes Equity Financing, Loan Facility for up to $47.5M

NEW YORK – PierianDx announced on Tuesday that it had closed $30 million of growth capital in the form of equity financing and a term loan facility, with access to additional tranches of up to $17.5 million by 2022 and 2023.

OrbiMed led the current investment round, with existing investors Health Catalyst Capital, Research Triangle Institute, Inova Health Systems, ATW Partners, and SJF Ventures also participating. The new financing is expected to drive PierianDx's commercial expansion as healthcare organizations bring next-generation sequencing capabilities in house, the St. Louis-based firm said.

Founded in 2014 as a spinout from Washington University in St. Louis, PierianDx partners with healthcare providers, laboratories, and medical centers to build on-site next-gen sequencing capabilities.

The company recently joined with Illumina and the Belgian Society of Medical Oncology to study the value of genomic profiling among advanced cancer patients. The BSMO is using PierianDx's Clinical Genomics Workspace platform to perform clinical interpretation of NGS results in that study.

PierianDx previously partnered with Illumina on NGS-based cancer panel reporting. The company raised $27 million in a Series B financing round in 2019.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.